EnteroMedics Profile

USD 0.07  3.54%
1.73Last Month High 2.24 
1.96Trading Day  High 2.09 

EnteroMedics exotic insider transaction detected

EnteroMedics Inc insider trading alert for general transaction of director option (right to buy) by Lori McDougal, the corporate stakeholder, on October 17, 2017. This event was filed by Enteromedics Inc with SEC on 2017-02-10. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

EnteroMedics Summary

EnteroMedics Inc (ETRM) is traded on Nasdaq Capital Markets in USA. It is located in MINNESOTA, U.S.A and employs 37 people. EnteroMedics is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 22.69 M. EnteroMedics Inc has 10.13 M outstanding shares of which 1.13 M shares are currently shorted by private and institutional investors with about 5.33 trading days to cover. ENTEROMEDICS INC. currently holds about 11.2 M in cash with (18.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.35.
Check EnteroMedics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected EnteroMedics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

EnteroMedics Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 83% 
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameEnteroMedics Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressSt. Paul, MN
ExchangeNasdaq Capital Markets
IndustryMedical Equipment
Contact Number651 634 3003
CurrencyUSD - US Dollar


EnteroMedics Analyst Recommendations
Target PriceAdvice# of Analysts
139.86Strong Buy1Odds
EnteroMedics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
EnteroMedics Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


EnteroMedics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-34.97March 1, 2017
EnteroMedics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate